Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Regadenoson Patent Expiration

Regadenoson is Used for cardiac imaging and increasing coronary blood flow. It was first introduced by Astellas Pharma Us Inc in its drug Lexiscan on Apr 10, 2008. 14 different companies have introduced drugs containing Regadenoson.


Regadenoson Patents

Given below is the list of patents protecting Regadenoson, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lexiscan US8106183 Process for preparing an A2A-adenosine receptor agonist and its polymorphs Feb 02, 2027 Astellas
Lexiscan US9085601 Process for preparing an A2A-adenosine receptor agonist and its polymorphs Feb 02, 2027 Astellas
Lexiscan USRE47301 Process for preparing an A2A-adenosine receptor agonist and its polymorphs Feb 02, 2027 Astellas
Lexiscan US6403567 N-pyrazole A2A adenosine receptor agonists Apr 10, 2022

(Expired)

 Astellas
Lexiscan US6642210 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists Jun 22, 2019

(Expired)

 Astellas
Lexiscan US7144872 N-pyrazole A2A receptor agonists Jun 22, 2019

(Expired)

 Astellas
Lexiscan US7183264 N-pyrazole A2A receptor agonists Jun 22, 2019

(Expired)

 Astellas
Lexiscan US7582617 Myocardial perfusion imaging method Jun 22, 2019

(Expired)

 Astellas
Lexiscan US7655636 Use of A2A adenosine receptor agonists Jun 22, 2019

(Expired)

 Astellas
Lexiscan US7655637 N-pyrazole A2A receptor agonists Jun 22, 2019

(Expired)

 Astellas
Lexiscan US7683037 Myocardial perfusion imaging method Jun 22, 2019

(Expired)

 Astellas
Lexiscan US8106029 Use of A2A adenosine receptor agonists Jun 22, 2019

(Expired)

 Astellas
Lexiscan US8133879 Myocardial perfusion imaging methods and compositions Jun 22, 2019

(Expired)

 Astellas
Lexiscan US8183226 Myocardial perfusion imaging method Jun 22, 2019

(Expired)

 Astellas
Lexiscan US8470801 Myocardial perfusion imaging methods and compositions Jun 22, 2019

(Expired)

 Astellas
Lexiscan US8536150 Methods of myocardial perfusion imaging Jun 22, 2019

(Expired)

 Astellas
Lexiscan US9045519 N-pyrazole A2A receptor agonists Jun 22, 2019

(Expired)

 Astellas
Lexiscan US9289446 Myocardial perfusion imaging methods and compositions Jun 22, 2019

(Expired)

 Astellas
Lexiscan USRE47351 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists Jun 22, 2019

(Expired)

 Astellas



Regadenoson's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Regadenoson Generic API Manufacturers

Several generic applications have been filed for Regadenoson. The first generic version for Regadenoson was by Accord Healthcare Inc and was approved on Apr 11, 2022. And the latest generic version is by Indies Pharma Jamaica Ltd and was approved on Aug 22, 2024.

Given below is the list of companies who have filed for Regadenoson generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Apr 11, 2022





2. APOTEX

Apotex Inc has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Apr 11, 2022


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Winnipeg Apotex Fermentation Inc.
Richmond Hill Apotex Inc.
Toronto Apotex Inc.
Etobicoke Apotex, Inc.
North York Apotex Inc.
Brantford Apotex Pharmachem Inc.
India
Bengaluru Apotex Research Private Limited
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bangalore Apotex Pharmachem India Pvt Ltd.





3. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP May 23, 2023





4. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Apr 11, 2022





5. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Oct 26, 2022


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Pashamylaram Eugia Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited





6. GE HEALTHCARE

Ge Healthcare has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Ge Healthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Aug 5, 2024


Manufacturing Plant Locations
New

Ge Healthcare's manufacturing plants are situated in 8 countries - United States, Norway, Austria, Finland, Ireland, Japan, United Kingdom, China. Given below are the details of these plant locations as well as the firm names of Ge Healthcare as present at those locations.

Country City Firm Name
United States
South Burlington GE Healthcare
Westborough GE Healthcare Biosciences
Oak Creek GE Healthcare - Repair Operations Center
Marlborough GE Healthcare Inc. - Life Sciences
Chicago GE Healthcare
Princeton GE Healthcare, Inc.
Arlington Heights GE Healthcare Inc.
Florence GE Healthcare LLC
Norway
Oslo GE Healthcare AS
Lindesnes GE Healthcare AS, Lindesnes Site
Austria
Pfaffing GE HEALTHCARE AUSTRIA GMBH & CO OG
Finland
Helsinki GE Healthcare Finland Oy
Ireland
Carrigtwohill GE Healthcare Ireland Limited
Japan
Hino GE Healthcare Japan Corporation
United Kingdom
Amersham GE Healthcare Ltd.
Gloucester GE Healthcare Ltd
China
Tianjin Ge Healthcare (Tianjin) Company
Shanghai GE Healthcare Shanghai Co., Ltd.





7. GLAND

Gland Pharma Ltd has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Gland.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Jul 12, 2022


Manufacturing Plant Locations
New

Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.

Country City Firm Name
India
Hyderabad Gland Pharma Limited
Sriperumbudur Gland Chemical Private Limited
Malur Gland Chemicals Pvt Ltd.
Hyderabad Gland Pharma Limited, Units I+II Pashamylaram Site
Aurangabad Gland Chemical Private Limited
Visakhapatnam Gland Pharma Limited
Parawada, Visakhapatnam Gland Pharma Limited





8. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Feb 2, 2023


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





9. HOSPIRA

Hospira Inc has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Aug 31, 2022


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Mcpherson Hospira, Inc., A Pfizer Company
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Morgan Hill Hospira Inc
Clayton Hospira, Inc.
Lake Forest Hospira Inc
Rocky Mount Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





10. IMS LTD

International Medication Systems Ltd has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Ims Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP May 23, 2022


Manufacturing Plant Locations
New

Ims Ltd's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Ims Ltd as present at those locations.

Country City Firm Name
United States
Shelton Ims Ltd





11. INDIES PHARMA

Indies Pharma Jamaica Ltd has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Indies Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Aug 22, 2024





12. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Apr 11, 2022





13. MYLAN

Mylan Pharmaceuticals Inc has filed for 1 generic for Regadenoson. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.4MG/5ML (0.08MG/ML)

solution Prescription INTRAVENOUS AP Apr 4, 2023


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Greensboro Mylan Pharmaceuticals Inc
San Carlos Mylan Pharmaceuticals Inc.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
Saint Albans Mylan Technologies, Inc.
Rockford Mylan Institutional, Inc.
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Morgantown Mylan Specialty, L.P.
India
Hosur Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Hyderabad Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Sarigam Mylan Laboratories Limited
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta